Dr. Shors has a track record of more than 30 years creating unique implantable medical devices for regenerative medicine. He has developed and commercialized synthetic bone graft substitutes, autogenous growth factors and allografts for bone reconstruction, as well as metallic orthopedic and dental implants. Prior to co-founding Biogennix, he was co-founder of Interpore International, which was acquired by Biomet in 2004 for $280 million. From 1978 to 2004, he served in a variety of senior management positions at Interpore International; including President, Chief Technology Officer and Vice President for research and development. Dr. Shors is also President of EC Shors Biomedical Consulting, Inc., which assists device companies with implants for regenerative medicine. Dr. Shors has a Ph.D. degree in Physiology and Biophysics from the University of Southern California.